Boehringer Ingelheim and WHO Foundation partner to boost healthcare access and suicide prevention in the Americas
Summary: Boehringer Ingelheim has partnered with the WHO Foundation, pledging $5 million to improve healthcare access for vulnerable populations in the Americas, particularly focusing on suicide prevention. This funding will support WHO’s General Program of Work from 2025 to 2028.
The collaboration aims to enhance equitable healthcare services and promote mental health initiatives. Boehringer Ingelheim's commitment includes backing evidence-based interventions and mobilizing additional resources from industry and philanthropy.
This marks Boehringer Ingelheim's first donation to WHO, expanding its support base and emphasizing the importance of public-private partnerships in addressing global health challenges.
This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.
My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.
Read more about how I calculate significance, or see today's top ranked news on the main page:
See today's news rankings